Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

673
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
673
Diversity of Protists I01:15

Diversity of Protists I

1.6K
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
1.6K
Bacterial Phylum Proteobacteria01:26

Bacterial Phylum Proteobacteria

1.1K
Proteobacteria, one of the largest and most diverse bacterial phyla, encompasses a wide range of Gram-negative bacteria distinguished by their outer membrane composed of lipopolysaccharides. These microorganisms exhibit various metabolic capabilities, including phototrophy, chemolithotrophy, and heterotrophy, and thrive in diverse environments from soil to aquatic systems and host-associated niches. The phylum is divided into six classes: Alphaproteobacteria, Betaproteobacteria,...
1.1K
Stringent Response in E. coli01:23

Stringent Response in E. coli

420
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
420
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

508
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
508
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.4K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.4K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Expanding cholera serosurveillance to vaccinated populations.

medRxiv : the preprint server for health sciences·2025
Same author

Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.

The Lancet. Infectious diseases·2025
Same author

Evolution of long COVID over two years in hospitalised and non-hospitalised survivors in Bangladesh: a longitudinal cohort study.

Journal of global health·2025
Same author

Physicians' Perspectives Regarding Informal Health Practitioners in Bangladesh.

The American journal of tropical medicine and hygiene·2025
Same author

Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol.

BMJ open·2025
Same author

Efficacy, Safety, and Immunogenicity of Biosimilar Adalimumab Advixa® Compared With Reference Product Humira® in Patients With Rheumatoid Arthritis in Bangladesh.

Cureus·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Feb 28, 2026

Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model
08:03

Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model

Published on: July 12, 2018

9.0K

El cólera

John D Clemens1, G Balakrish Nair2, Tahmeed Ahmed3

  • 1International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research, Dhaka, Bangladesh; UCLA Fielding School of Public Health, Los Angeles, CA, USA; Korea University School of Medicine, Seoul, Korea.

Lancet (London, England)
|March 18, 2017
PubMed
Resumen

El cólera, una enfermedad diarreica grave, sigue causando 100.000 muertes al año a pesar de las efectivas terapias de rehidratación. Las nuevas vacunas orales, aprovechando la inmunidad intestinal, ofrecen protección contra esta persistente amenaza para la salud mundial.

Más Videos Relacionados

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
07:58

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates

Published on: May 30, 2017

11.6K
Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
09:39

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages

Published on: May 30, 2013

10.5K

Videos de Experimentos Relacionados

Last Updated: Feb 28, 2026

Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model
08:03

Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model

Published on: July 12, 2018

9.0K
Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
07:58

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates

Published on: May 30, 2017

11.6K
Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
09:39

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages

Published on: May 30, 2013

10.5K

Área de la Ciencia:

  • Enfermedades infecciosas
  • Salud pública
  • Vacunas y vacunas

Sus antecedentes:

  • El cólera es una enfermedad diarreica aguda y acuosa causada por los serogrupos Vibrio cholerae O1 u O139.
  • Históricamente, el cólera ha causado múltiples pandemias globales originadas en el delta del Ganges e Indonesia.
  • A pesar de los avances en la terapia de rehidratación que han reducido la tasa de mortalidad a menos del 1%, el cólera sigue causando aproximadamente 100.000 muertes al año, principalmente en los países en desarrollo.

Objetivo del estudio:

  • Proporcionar una visión general del cólera, incluida su epidemiología, su impacto histórico y su importancia actual para la salud pública.
  • Destacar los avances en la gestión de casos de cólera y el desarrollo de vacunas eficaces.
  • Discutir el papel de la inmunidad intestinal local en el desarrollo de vacunas protectoras contra el cólera.

Principales métodos:

  • Revisión de los datos históricos sobre pandemias de cólera y mortalidad.
  • Análisis de los datos epidemiológicos actuales sobre la incidencia y la mortalidad por cólera.
  • Resumen de la comprensión científica de la patogénesis del cólera y las respuestas inmunológicas.
  • Visión general del desarrollo y almacenamiento de vacunas contra el cólera.

Principales resultados:

  • La mortalidad por cólera se ha reducido a menos del 1% a través de la rehidratación oral e intravenosa.
  • Se estima que 100.000 muertes por cólera ocurren anualmente, predominantemente en regiones endémicas de los países en desarrollo.
  • Se han desarrollado vacunas orales seguras y efectivas contra el cólera, basadas en la comprensión de la inmunidad intestinal, y se almacenan en todo el mundo.

Conclusiones:

  • El cólera sigue siendo un importante desafío para la salud mundial, especialmente en entornos de bajos recursos.
  • La terapia de rehidratación oral ha mejorado dramáticamente las tasas de supervivencia del cólera.
  • El desarrollo de vacunas orales contra el cólera representa un gran avance en el control de la epidemia y el cólera endémica.